Bojian Zheng

Title: Inventor Bojian Zheng: Pioneering Peptide-Based Solutions for Respiratory Virus Infections

Introduction

Bojian Zheng, an accomplished inventor based in Hong Kong, China, holds a total of six patents dedicated to advancing medical science. His innovative research primarily focuses on developing peptide-based methods for preventing and treating respiratory virus infections, a critical area of study given the global health challenges posed by viral pathogens.

Latest Patents

Among Bojian Zheng’s latest contributions to science is a groundbreaking patent that reveals a method for preventively treating subjects at risk of developing infections from respiratory viruses. This method involves administering a peptide synthesized through chemical or genetic engineering means. The peptide is characterized by a functional domain that binds to the surface glycoproteins of respiratory viruses and effectively inhibits infections caused by these viruses. Importantly, the peptide consists of five or more basic amino acids, with at least two of these located in the N-terminal or C-terminal regions, and maintains an amino acid sequence that is 90% identical to a given reference sequence. The patent outlines the mechanism by which these peptides inhibit infections, aimed at supporting the development of new broad-spectrum antiviral agents.

Additionally, another patent by Zheng emphasizes the role of peptides in blocking respiratory virus infections, showcasing their utility in both prevention and treatment. Zheng’s patents also include a kit for screening peptides capable of inhibiting these infections along with methods for conducting such screenings, further enhancing the toolkit available for researchers and clinicians in the field.

Career Highlights

Bojian Zheng has collaborated with notable organizations such as Xiangxue Group (Hong Kong) Company Limited and Sirnaomics, Inc. His work reflects a commitment to translating research innovation into practical solutions for health challenges faced globally. His patent portfolio demonstrates his expertise and dedication to advancing the field of antiviral peptide research.

Collaborations

Throughout his career, Zheng has worked closely with proficient colleagues, including Hanjun Zhao and Hongyan Sui. These collaborations have facilitated the integration of diverse insights and expertise, thus enhancing the quality and impact of their collective research.

Conclusion

Bojian Zheng stands out as a significant figure in the realm of medical inventions, particularly for his efforts in addressing respiratory virus infections through peptide innovation. His patents not only provide immediate applications in therapeutic settings but also lay the groundwork for future research initiatives aimed at combating viral infections. As the landscape of global health continues to evolve, inventors like Zheng play an essential role in the ongoing quest for effective medical solutions.